Predictive value of IL28b gene polymorphism combined with pretreatment serum IP-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any of these biomarkers alone

Details for Australian Patent Application No. 2010334918 (hide)

Owner Janssen R&D Ireland

Inventors Aerssens, Jeroen; Fanning, Gregory Charles; Fried, Michael W.

Agent Shelston IP

Pub. Number AU-A-2010334918

PCT Pub. Number WO2011/076814

Priority 10175297.0 03.09.10 EP; 09180387.4 22.12.09 EP

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/076814 Priority application(s): WO2011/076814

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010334919-Teether

2010334915-Carboxamide compounds and their use as calpain inhibitors